Lrig1 anticorps (C-Term)
Aperçu rapide pour Lrig1 anticorps (C-Term) (ABIN7466577)
Antigène
Voir toutes Lrig1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Épitope
- C-Term
-
Specificité
- Knockdown/Knockout validation was supported by customer review data.
-
Réactivité croisée
- Humain, Souris
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein encompassing a sequence within the C-terminus region of human LRIG1. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
Validation: KO/KD
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.61 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
-
Autre désignation
- leucine rich repeats and immunoglobulin like domains 1
-
Sujet
- Leucine rich repeats and immunoglobulin like domains 1 , LIG-1 , LIG1,Act as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.
-
Poids moléculaire
- 119 kDa
-
ID gène
- 26018
-
UniProt
- Q96JA1
Antigène
-